Vol. 9 No. 2 (2022): European Journal of Rheumatology

Published: 2022-04-26

Original Article

Next-Generation Sequencing Analysis of MVK, NLRP3, TNFRSF1A, and PSTPIP1 Genes in Patients without MEFV Gene Variation and Genotype–Phenotype Correlation

Gamze Vuran, Afig Berdeli

(62-67)

DOI: https://doi.org/10.5152/eurjrheum.2022.21049
Full Text PDF Abstract

Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?

Belkıs Nihan Coşkun, Burcu Yağız, Seniha Gündüz Çorabay, Yavuz Pehlivan, Ediz Dalkılıç

(68-74)

DOI: https://doi.org/10.5152/eurjrheum.2022.21099
Full Text PDF Abstract

Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients

Hazan Karadeniz, Hakan Babaoğlu, Aslıhan Avanoğlu Güler, Reyhan Bilici Salman, Hasan Satış, Nuh Ataş, Berna Göker, Şeminur Haznedaroğlu, Mehmet Akif Öztürk, Abdurrahman Tufan, Emetullah Cindil

(75-81)

DOI: https://doi.org/10.5152/eujrheum.2022.21067
Full Text PDF Abstract

A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry

Ayşe Cefle, Nurullah Akkoç, Haner Direskeneli, Fatih Yıldız, Gözde Yildirim Çetin, Şule Yavuz, Seminur Haznedaroğlu, Berna Göker, Özgül Soysal Gündüz, Cemal Bes, Şükran Erten, Neslihan Yılmaz, Niels Steen Krogh, Servet Yolbaş, Mehmet Akif Öztürk, Fatoş Önen, Dilek Solmaz, Merih Birlik, İsmail Sarı, Nevsun İnanç, Sema Yılmaz, Ayten Yazıcı, Abdurrahman Tufan, Süleyman Serdar Koca, Servet Akar, Soner Şenel, Yavuz Pehlivan, Ediz Dalkılıç, Sedat Çapar, Gerçek Can

(82-87)

DOI: https://doi.org/10.5152/eurjrheum.2022.21060
Full Text PDF Abstract

A comparison of rituximab with cyclophosphamide in terms of efficacy and complications as induction therapy for treating granulomatosis with polyangiitis: A three-center study

Maryam Tavakoli Chaleshtori, Ziba Farajzadegan, Mansour Salesi

(88-92)

DOI: https://doi.org/10.5152/eurjrheum.2022.21063
Full Text PDF Abstract

Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course

Anam Tariq, Ayobami Akenroye, Antoine Azar, Philip Seo, Duvuru Geetha

(93-99)

DOI: https://doi.org/10.5152/eujrheum.2022.20258
Full Text PDF Abstract

How well are biologic and conventional DMARDs tolerated in psoriatic arthritis: A real world study

Issrah I. Jawad, Muhammed K. Nisar

(100-103)

DOI: https://doi.org/10.5152/eurjrheum.2021.21027
Full Text PDF Abstract

Case-Based Review

Adalimumab-Induced Lupus Nephritis: Case Report and Review of the Literature

Brigitte Kazzi, Brent Gudenkauf, Derek Fine, Jose Manuel Monroy-Trujillo, Antoine Azar, Gabriel Giannini, Homa Timlin

(108-110)

DOI: https://doi.org/10.5152/eurjrheum.2022.21059
Full Text PDF Abstract

Sitagliptin-induced Achilles enthesopathy: Case report and literature review

Ibrahim Halil Rızvanoğlu, Bünyamin Kısacık

(111-113)

DOI: https://doi.org/10.5152/eujrheum.2022.21124
Full Text PDF Abstract

Letter to the Editor

Screening for Leishmania specific antibodies among patients with rheumatic diseases treated with biological therapy

Fruzsina Szabados, Henrik Vedel Nielsen, Kurt Fuursted, Asta Linauskas, Claus Rasmussen, Peter Derek Christian Leutscher

(114-115)

DOI: https://doi.org/10.5152/eurjrheum.2022.20105
Full Text PDF Abstract

Images in Rheumatology

Pigmented villus fragments on synovial fluid examination

Ufuk İlgen, Hakan Emmungil

(104-105)

DOI: https://doi.org/10.5152/eurjrheum.2021.20152
Full Text PDF Abstract

Iatrogenic Cushing’s syndrome from topical steroid use

Vivek Arya, Ashish Sharma, Mohammad Ali

(106-107)

DOI: https://doi.org/10.5152/eurjrheum.2021.20154
Full Text PDF Abstract